Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
32.97
+0.15 (0.44%)
Feb 11, 2026, 4:00 PM EST - Market closed

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Immunotherapies
310.20M
Immunotherapies Growth
24.37%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
United States
226.90M
United States Growth
25.72%
Europe
73.22M
Europe Growth
8.27%
International
10.08M
International Growth
665.81%